Sign up to save your podcasts
Or
Share A Learner Pathway in Moderate-to-Severe AD: Expert Mentoring on Challenging Patient Cases
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Learner Pathway in Moderate-to-Severe AD: Expert Mentoring on Challenging Patient Cases
CME credits: 0.50
Valid until: 24-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/learner-pathway-moderate-severe-ad-expert-mentoring-challenging-patient-cases-care-team-forum/10967/
“I begged my doctor for something else – there had to be something else,” Pam.
For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of the several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 24-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/learner-pathway-moderate-severe-ad-expert-mentoring-challenging-patient-cases-care-team-forum/10967/
“I begged my doctor for something else – there had to be something else,” Pam.
For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of the several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.